drugset / Trial / NCT00844675

Effects of Oral Rabeprazole on the Prevention of Ulcer Bleeding Following Endoscopic Mucosal Resection

NCT00844675

RandomizedParallel-groupTriple-blindPrevention

Summary

The purpose of this study is: * To examine if oral administration of Pariet (proton pump inhibitor, 20mg tablets, twice daily for 5 days) before Endoscopic mucosal resection(EMR) exhibits preventive effects of ulcer bleeding compared with placebo group (preoperative administration of placebo) * To evaluate the effects on the suppression of acid secretion of preoperative administration of an Proton pump inhibitor

Timeline

Start
2007-10
Primary completion
2011-12
Completion
2012-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Rabeprazole Small molecule 20 mg Oral